Publications by authors named "Anna C Adams"

Article Synopsis
  • * Producing oligoclonal antibodies in a single batch is more cost-effective than making multiple individual monoclonal antibody batches, making the manufacturing process more efficient.
  • * The study successfully created a stable oligoclonal antibody mixture targeting toxins from various elapid snake venoms, demonstrating a viable strategy for producing tailored antivenoms for snakebites and potentially other medical applications.
View Article and Find Full Text PDF

Improved therapies are needed against snakebite envenoming, which kills and permanently disables thousands of people each year. Recently developed neutralizing monoclonal antibodies against several snake toxins have shown promise in preclinical rodent models. Here, we use phage display technology to discover a human monoclonal antibody and show that this antibody causes antibody-dependent enhancement of toxicity (ADET) of myotoxin II from the venomous pit viper, Bothrops asper, in a mouse model of envenoming that mimics a snakebite.

View Article and Find Full Text PDF

Current snakebite antivenoms are based on polyclonal animal-derived antibodies, which can neutralize snake venom toxins in envenomed victims, but which are also associated with adverse reactions. Therefore, several efforts within antivenom research aim to explore the utility of recombinant monoclonal antibodies, such as human immunoglobulin G (IgG) antibodies, which are routinely used in the clinic for other indications. In this study, the feasibility of using tobacco plants as bioreactors for expressing full-length human monoclonal IgG antibodies against snake toxins was investigated.

View Article and Find Full Text PDF